Teacher Retirement System of Texas boosted its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 780.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,102 shares of the insurance provider’s stock after purchasing an additional 6,295 shares during the quarter. Teacher Retirement System of Texas’ holdings in Humana were worth $1,802,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. FPC Investment Advisory Inc. acquired a new stake in Humana during the fourth quarter worth about $27,000. Centricity Wealth Management LLC bought a new stake in shares of Humana during the fourth quarter valued at approximately $30,000. LFA Lugano Financial Advisors SA raised its stake in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new position in Humana in the fourth quarter worth $33,000. Finally, Atwood & Palmer Inc. boosted its stake in Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after buying an additional 60 shares in the last quarter. 92.38% of the stock is owned by institutional investors.
Humana Price Performance
Shares of HUM stock opened at $270.04 on Friday. The firm’s 50 day moving average price is $270.51 and its two-hundred day moving average price is $274.93. The stock has a market cap of $32.59 billion, a PE ratio of 27.14, a PEG ratio of 2.05 and a beta of 0.57. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.31%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s payout ratio is presently 35.58%.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on the stock. Piper Sandler increased their price objective on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Barclays raised their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. StockNews.com cut Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. Finally, Morgan Stanley cut their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Eighteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Humana presently has an average rating of “Hold” and a consensus price target of $285.68.
Check Out Our Latest Research Report on Humana
Insiders Place Their Bets
In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.37% of the company’s stock.
About Humana
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- Want to Profit on the Downtrend? Downtrends, Explained.
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- About the Markup Calculator
- Top 3 Beverage Stocks Pouring Out Profits
- How to Invest in Biotech Stocks
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.